Important: This is a business-facing draft for website use. Doxely Medica’s qualified legal adviser should review it before public launch and whenever commercial, privacy or regulatory requirements change.
1. Scope and acceptance
These Terms & Conditions apply to visitors using this website and to company registrations, product enquiries, quote requests and related communications. By using the website or submitting an enquiry, you agree to these terms. They do not create a supply contract by themselves.
2. Company authority and accurate information
Anyone submitting a business registration or quote enquiry confirms that they are authorised to act for the named company and that the information supplied is accurate, complete and current. Doxely Medica may rely on that information when assessing the enquiry.
3. Quotes, orders and commercial discretion
A website enquiry is a request for information or quotation, not an offer accepted by Doxely Medica. Prices, product availability, delivery arrangements, payment terms, taxes, product eligibility and regulatory requirements are confirmed only in Doxely Medica’s written quotation or other written confirmation. Doxely Medica may, subject to applicable law and regulatory obligations, decide whether to respond to, quote for, accept, decline, limit or discontinue an enquiry, commercial relationship or supply request.
4. Product information and medical advice
Catalogue and website information is provided for general business and product-information purposes. It is not medical advice, a diagnosis, a prescription, an individual treatment recommendation or a guarantee of suitability. Customers and end users must seek advice from qualified healthcare professionals where appropriate and follow applicable product labelling, instructions and professional requirements.
5. Regulatory compliance and responsible distribution
Each customer is responsible for holding and maintaining any licences, permits, registrations, approvals, storage arrangements and professional authorisations required for its activities. Customers must comply with applicable laws, anti-bribery and anti-corruption obligations, sanctions and trade-control requirements, product-handling requirements, and all relevant national regulatory requirements. Doxely Medica may request reasonable documentation before progressing an enquiry or supply arrangement.
6. Availability, product changes and quality concerns
Catalogue content, product information and published In Stock indications may change. A displayed In Stock label is informational and remains subject to final confirmation. If a customer identifies a suspected product-quality issue, complaint, damage, temperature concern, suspected falsification or recall-related issue, it should stop distribution or use where appropriate, preserve the relevant product and packaging, and contact Doxely Medica promptly with the batch, product, quantity and relevant details. Any required notification to authorities remains the responsibility of the appropriate party under applicable law.
7. Confidentiality and discretion
Commercial, pricing, product-source, customer, supply-chain, quotation and other non-public information exchanged in connection with an enquiry should be treated as confidential and used only to evaluate or perform the potential business relationship. Neither party may disclose such information to a third party without the other party’s consent, except to its professional advisers, service providers or affiliates who need to know it and are bound by confidentiality obligations, or where disclosure is required by law, regulatory authority or a valid legal process.
8. Electronic acceptance record
When a signatory ticks the agreement box and types their full name and role, the website records an electronic acceptance record containing the named company, signatory name, signatory role, terms version and server timestamp. This record is associated with the submitted enquiry. Its legal effect may vary by jurisdiction and should be reviewed by legal counsel.
9. Website use, intellectual property and third-party links
The Doxely Medica name, logo, website design, text, images and other website materials are protected by applicable intellectual-property rights. They may not be copied, altered, republished, used to imply endorsement or used for a commercial purpose without written permission, except for ordinary personal or internal business use of the website. Links to third-party sites are provided for convenience only; Doxely Medica does not control, endorse or accept responsibility for their content, availability or privacy practices.
10. Website availability and limitation of liability
Doxely Medica aims to keep website information current and the website available, but does not guarantee that the website will be uninterrupted, error-free, complete or current at every moment. To the maximum extent permitted by applicable law, Doxely Medica is not liable for indirect, incidental, special, consequential or business-interruption losses arising from website use, reliance on preliminary catalogue information, or third-party websites. Nothing in these terms excludes liability that cannot lawfully be excluded or limited.
11. Force majeure
Doxely Medica is not responsible for delay or failure to perform an obligation caused by events beyond its reasonable control, including regulatory action, shortage, transport disruption, port or customs delay, public-health emergency, natural event, utility or communications failure, conflict, labour disruption or supplier failure. The affected party will use reasonable efforts to reduce the impact where appropriate.
12. Privacy, changes and governing law
Doxely Medica may use submitted information to assess an enquiry, communicate with the registering company and manage a potential commercial relationship, in accordance with its applicable privacy notice and law. These terms may be updated from time to time; the version displayed when an electronic acceptance is recorded applies to that record. Governing law and dispute-resolution provisions should be confirmed by Doxely Medica’s legal adviser before launch.
13. Contact
For a question about these terms, a quality concern or a submitted enquiry, contact Doxely Medica through the website Contact page.
Version 1.1 · Effective 17 September 2026